Literature DB >> 12091173

Spirometry in 3- to 6-year-old children with cystic fibrosis.

Paulo J C Marostica1, Andrea D Weist, Howard Eigen, Connie Angelicchio, Kathy Christoph, Julie Savage, Debra Grant, Robert S Tepper.   

Abstract

Spirometry is routinely used to assess pulmonary function of older children and adults with cystic fibrosis (CF); however, few data exist concerning the preschool age group. We have reported normative spirometric data for 3- to 6-year-old children. The current study was designed to assess a similarly aged group of clinically stable patients with CF. Thirty-three of 38 children with CF were able to perform 2 or 3 technically acceptable maneuvers. These patients had significantly decreased FVC, FEV(1), FEV(1)/FVC, and FEF(25-75) when expressed as z scores (number of SD from predicted): -0.75 +/- 1.63, -1.23 +/- 1.97, -0.87 +/- 1.33, and -0.74 +/- 1.63, respectively. There were significant positive correlations of the Brasfield radiological score with FVC and FEV(1) z scores (r(2) = 0.26, p < 0.01 and r(2) = 0.24, p < 0.01). In addition, homozygous patients for the DeltaF508 mutation had lower z scores for FVC (-1.21 versus 0.47, p < 0.01) and FEV(1) (-1.38 versus 0.21, p < 0.05) than heterozygous patients. Of the 14 patients who had full flow-volume spirometric measurements during infancy, 10 had FEF(25-75) z scores greater than -2 at both evaluations. Our findings suggest that spirometry can successfully be used to assess lung function in preschool children with CF and has the potential for longitudinal assessment from infancy through adulthood.

Entities:  

Mesh:

Year:  2002        PMID: 12091173     DOI: 10.1164/rccm.200111-056OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  Abnormal Lung Clearance Index in Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID) Children with Otherwise Normal FEV1.

Authors:  Ajay S Kasi; Choo Phei Wee; Thomas G Keens; Danieli B Salinas
Journal:  Lung       Date:  2019-12-16       Impact factor: 2.584

2.  Early pulmonary disease manifestations in cystic fibrosis mice.

Authors:  Rebecca J Darrah; Anna L Mitchell; Cara K Campanaro; Eric S Barbato; Paul Litman; Abdus Sattar; Craig A Hodges; Mitchell L Drumm; Frank J Jacono
Journal:  J Cyst Fibros       Date:  2016-05-24       Impact factor: 5.482

3.  Clinically useful spirometry in preschool-aged children: evaluation of the 2007 American Thoracic Society Guidelines.

Authors:  Jonathan M Gaffin; Nancy Lichtenberg Shotola; Thomas R Martin; Wanda Phipatanakul
Journal:  J Asthma       Date:  2010-09       Impact factor: 2.515

Review 4.  Endpoints for clinical trials in young children with cystic fibrosis.

Authors:  Stephanie D Davis; Alan S Brody; Mary J Emond; Lyndia C Brumback; Margaret Rosenfeld
Journal:  Proc Am Thorac Soc       Date:  2007-08-01

5.  Efficacy, safety, and local pharmacokinetics of highly concentrated nebulized tobramycin in patients with cystic fibrosis colonized with Pseudomonas aeruginosa.

Authors:  Gerard Lenoir; Yuriy Genadievich Antypkin; Angelo Miano; Paolo Moretti; Maurizio Zanda; Guido Varoli; Pier Alessandro Monici Preti; Nikolay Leonidovich Aryayev
Journal:  Paediatr Drugs       Date:  2007       Impact factor: 3.022

6.  AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations.

Authors:  Rebecca J Darrah; Frank J Jacono; Neha Joshi; Anna L Mitchell; Abdus Sattar; Cara K Campanaro; Paul Litman; Jennifer Frey; David E Nethery; Eric S Barbato; Craig A Hodges; Harriet Corvol; Garry R Cutting; Michael R Knowles; Lisa J Strug; Mitchell L Drumm
Journal:  J Cyst Fibros       Date:  2018-06-22       Impact factor: 5.482

7.  Reference values of Forced Expiratory Volumes and pulmonary flows in 3-6 year children: a cross-sectional study.

Authors:  Pavilio Piccioni; Alberto Borraccino; Maria Pia Forneris; Enrica Migliore; Carlo Carena; Elisabetta Bignamini; Stefania Fassio; Giorgio Cordola; Walter Arossa; Massimiliano Bugiani
Journal:  Respir Res       Date:  2007-02-22

Review 8.  Lung function tests to monitor respiratory disease in preschool children.

Authors:  Valentina Fainardi; Enrico Lombardi
Journal:  Acta Biomed       Date:  2018-06-14

9.  Hyperinflation is associated with increased respiratory rate and is a more sensitive measure of cystic fibrosis lung disease during infancy compared to forced expiratory measures.

Authors:  Heather N Muston; James E Slaven; Christina Tiller; Charles Clem; Thomas W Ferkol; Sarath Ranganathan; Stephanie D Davis; Clement L Ren
Journal:  Pediatr Pulmonol       Date:  2021-06-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.